Literature DB >> 3024026

Adenosine analogs mediating depressant effects on synaptic transmission in rat hippocampus: structure-activity relationships for the N6 subregion.

T V Dunwiddie, T S Worth, R A Olsson.   

Abstract

Previous studies have shown that analogs of adenosine with substituents upon the N6-nitrogen (e.g., N6-[1-phenyl-2(R)-propyl]adenosine; R-PIA) are often much more potent than the parent compound in activating adenosine receptors, particularly those of the A1 subtype. The present investigation characterized the potencies of a number of N6-substituted adenosine analogs in depressing excitatory synaptic transmission in slices of rat hippocampus, an electrophysiological response mediated by receptors of the A1 subtype. These potencies correlated well with previously reported affinities of these analogs for A1 receptor sites in brain, but not with coronary vasodilation in the dog heart, an A2 receptor mediated response. Analogs with alkyl or aryl substituents at the N6 position were generally more potent than adenosine, although analogs with a tertiary carbon attached directly to the N6-nitrogen were usually only weakly active. Although it has been suggested that there may be a subregion of the A1 receptor with some specificity for aryl groups, these experiments did not suggest that this was the case. Analogs with chiral centers attached to the N6-nitrogen usually displayed stereoselectivity, with R-isomers more potent than the S-isomers. The mechanism underlying this selectivity appeared to be both a facilitating effect of alkyl substituents in the propyl C1 position of R-PIA, and a hindering effect of substituents in the position normally occupied by the hydrogen attached to propyl C2 of R-PIA. These results indicate that although there are some similarities in terms of requirements for activity at A1 and A2 receptors, differences between the N6 sub-regions of these receptors are sufficient to permit the development of selective analogs for these two receptor sites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024026     DOI: 10.1007/bf00498743

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Interhippocampal impulses. II. Apical dendritic activation of CAI neurons.

Authors:  P ANDERSEN
Journal:  Acta Physiol Scand       Date:  1960-03-18

2.  The inhibitory effect of adenosine and related nucleotides on the release of acetylcholine.

Authors:  E S Vizi; J Knoll
Journal:  Neuroscience       Date:  1976       Impact factor: 3.590

3.  The adenosine receptor activity of EMD 28422, a purine derivative with reported actions on benzodiazepine receptors.

Authors:  T V Dunwiddie; B B Fredholm; B Jonzon; G Sandberg
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

4.  Analysis and quantitative evaluation of the depressive effect of adenosine on evoked potentials in hippocampal slices.

Authors:  P Schubert; U Mitzdorf
Journal:  Brain Res       Date:  1979-08-17       Impact factor: 3.252

5.  An A1-adenosine receptor, characterized by [3H] cyclohexyladenosine binding, mediates the depression of evoked potentials in a rat hippocampal slice preparation.

Authors:  M Reddington; K S Lee; P Schubert
Journal:  Neurosci Lett       Date:  1982-03-05       Impact factor: 3.046

6.  The dextro and levorotatory isomers of N-phenylisopropyladenosine: stereospecific effects on cyclic AMP-formation and evoked synaptic responses in brain slices.

Authors:  F W Smellie; J W Daly; T V Dunwiddie; B J Hoffer
Journal:  Life Sci       Date:  1979-11-12       Impact factor: 5.037

7.  Adenosine receptors mediating cyclic AMP production in the rat hippocampus.

Authors:  B B Fredholm; B Jonzon; E Lindgren; K Lindström
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

8.  Adenosine inhibition of gamma-aminobutyric acid release from slices of rat cerebral cortex.

Authors:  C Hollins; T W Stone
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

9.  Electrophysiological responses to adenosine analogs in rat hippocampus and cerebellum: evidence for mediation by adenosine receptors of the A1 subtype.

Authors:  T V Dunwiddie; A S Basile; M R Palmer
Journal:  Life Sci       Date:  1984-01-02       Impact factor: 5.037

10.  Noradrenergic responses in rat hippocampus: evidence for medication by alpha and beta receptors in the in vitro slice.

Authors:  A L Mueller; B J Hoffer; T V Dunwiddie
Journal:  Brain Res       Date:  1981-06-09       Impact factor: 3.252

View more
  5 in total

1.  Neurotransmitter activation of inwardly rectifying potassium current in dissociated hippocampal CA3 neurons: interactions among multiple receptors.

Authors:  D L Sodickson; B P Bean
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

2.  Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices.

Authors:  S Latini; F Bordoni; F Pedata; R Corradetti
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation.

Authors:  T M Delahunty; M J Cronin; J Linden
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

4.  Behavioral effects of A1- and A2-selective adenosine agonists and antagonists: evidence for synergism and antagonism.

Authors:  O Nikodijević; R Sarges; J W Daly; K A Jacobson
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

5.  Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists.

Authors:  K A Jacobson; O Nikodijevic; X D Ji; D A Berkich; D Eveleth; R L Dean; K Hiramatsu; N F Kassell; P J van Galen; K S Lee
Journal:  J Med Chem       Date:  1992-10-30       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.